We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We may also share information about your use of our site with our social media, advertising and analytics partners. Read more about our Privacy Policy.

I got it!

RNA Therapeutics

Innovations in technologies and applications of RNA-based medicine

RNA therapeutics is a rapidly expanding industry with increasingly growing potential for immunotherapy personalised medicines, and treatment of genetic, infectious and chronic diseases. This is reflected with the value of the global antisense & RNA therapeutics market expected to reach USD billion by 2025, growing at a CAGR of Furthermore, the recent advent of CRISPR, an RNA-guided gene-editing technology, as well as new strides in the delivery of messenger RNA transcribed in vitro, have triggered a major expansion of the RNA-therapeutics field.

The 2021 conference is set to explore the latest developments in RNA delivery agents and RNA-based therapeutics with the latest case studies on advanced mRNA technologies, oligonucleotide delivery, therapeutic applications and future trends and innovations.

Join us in February 2021, as SMi’s 12th annual RNA Therapeutics Conference brings together industry experts from leading RNA therapeutics companies to gain an expert and holistic view on the latest developments in the industry, upcoming regulatory updates and industry implications.

BENEFITS OF ATTENDING:

  • Explore in industry insights into how mRNA is being used to combat COVID-19
  • Engage in case studies exploring the growing therapeutic potential of RNA for rare diseases
  • Delve into future trends in AI application for optimal RNA therapeutics
  • Hear regulatory outlooks of the RNA landscape, clinical trials and looking ahead

View the full agenda and speaker line-up online:

Chairs for 2021:

Heinrich Haas, VP RNA Formulation and Drug Delivery, BioNTech

Focus Day Chair for 2021: Shalini Andersson, Chief Scientist New Therapeutic Modalities & Head of Oligonucleotide Discovery, AstraZeneca

Featured speakers:

•             Dong Yu, Fellow, Senior Director, and Head, GSK Vaccines

•             Maria Luisa Pineda, CEO and Co-Founder, Envisagenics

•             Kirsty Wydenbach, Deputy Unit Manager/Senior Medical Assessor, MHRA

•             Dong Ki Lee, CEO, OliX

•             Jennifer Pluim, Vice President Medical Affairs, ProQR

•             Arpan Desai, Team Leader, Advanced Drug Delivery, Pharmaceutical Sciences, AstraZeneca

•             Ruchi Shah, Senior Research Engineer, New Therapeutics Modalities, Eli Lilly and Company

•             Michael Mulqueen, Vice President Business Development, eTheRNA immunotherapies

•             Troels Koch, Founder & CEO, Aqiventa

Who should attend:

  • Research & Development Directors/Managers/Scientists
  • Heads of Clinical Development
  • Heads of Pre-Clinical Development
  • Head of RNA Biology
  • Head of RNA Formulation and Drug Delivery
  • Head of Pre-clinical R&D
  • Head of New Modalities
  • Head of Discovery
  • Senior Scientists
  • Chief Scientific Officers
  • Chief Medical Officers

Registrations can be made on the event website at:

Additional Contact Info:

T: +44 (0)20 7827 6088

E: /> Follow us:  @SMiPharm #SMirna

When

10 Feb 2021 @ 09:00 am

11 Feb 2021 @ 09:01 am

Duration: 1 days

Timezone:


Where

Online Webinar


Organised by

SMi Group Ltd.

Other Events in Health

Similar Webinars in Health

Recent Publications in Health

Recent Videos in Health

Recent Speakers in Health

Donald Jones
Event-Co-ordinate

1

Steven Wachs
Speaker

1

Neil P J Price
Research Scientist

4

Recent News in Health

#EB148 Day 3 https://t.co/fNRifhrKnq

@WHO_Europe - 20 Jan 2021 16:48

📢 PRESS RELEASE: So far ‘worst case scenario’ avoided but #Brexit impact on #fruit & #vegetable sector mounting wit… https://t.co/6Jypey1CzG

@Freshfel - 20 Jan 2021 15:09

You can prevent raised blood pressure by: 🔵Reducing salt intake 🔵Eating fruits & vegetables 🔵Avoiding transfats 🔵A… https://t.co/NCZelV6COQ

@WHO_Europe - 20 Jan 2021 14:45